TWI767019B - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDFInfo
- Publication number
- TWI767019B TWI767019B TW107122210A TW107122210A TWI767019B TW I767019 B TWI767019 B TW I767019B TW 107122210 A TW107122210 A TW 107122210A TW 107122210 A TW107122210 A TW 107122210A TW I767019 B TWI767019 B TW I767019B
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- formula
- crystal alignment
- weight
- solvent
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nonlinear Science (AREA)
- General Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
本發明是關於一種液晶配向劑及其製造方法、液晶配向膜及其製造方法及液晶顯示元件,特別是關於一種噴墨印刷塗佈性佳的液晶配向劑及其製造方法、由上述液晶配向劑形成的液晶配向膜及其製造方法以及具有上述液晶配向膜的液晶顯示元件。The present invention relates to a liquid crystal alignment agent and a method for producing the same, a liquid crystal alignment film and a method for producing the same, and a liquid crystal display element, in particular to a liquid crystal alignment agent with good inkjet printing coating properties and a method for producing the same, and the liquid crystal alignment agent described above. The formed liquid crystal alignment film, its manufacturing method, and the liquid crystal display element provided with the said liquid crystal alignment film.
由於消費者對液晶顯示器的廣視角特性的要求逐年提升,使得具廣視角的液晶顯示元件的電性特性或顯示特性的要求比以往更為嚴苛,其中,以垂直配向型(Vertical Alignment)液晶顯示元件最被廣為研究。為了具有較佳上述的特性,液晶配向膜便成為提升垂直配向型液晶顯示元件特性的重要研究對象之一。As consumers' requirements for the wide viewing angle characteristics of liquid crystal displays are increasing year by year, the requirements for the electrical characteristics or display characteristics of liquid crystal display elements with wide viewing angles are more stringent than before. Display elements are the most widely studied. In order to have the above-mentioned characteristics better, the liquid crystal alignment film has become one of the important research objects to improve the characteristics of the vertical alignment type liquid crystal display element.
該垂直配向型液晶顯示元件中的液晶配向膜主要是被用來使液晶分子有規則的排列以及在未提供電場下可使液晶分子具有一大的傾斜角度,且液晶配向膜的形成方式通常是將一含有聚醯胺酸聚合物、聚醯亞胺聚合物等高分子材料的液晶配向劑塗佈於一基板表面,經加熱處理及配向處理後而形成。The liquid crystal alignment film in the vertical alignment type liquid crystal display element is mainly used to arrange the liquid crystal molecules regularly and to make the liquid crystal molecules have a large inclination angle without an electric field, and the formation method of the liquid crystal alignment film is usually A liquid crystal alignment agent containing polymer materials such as polyimide polymer and polyimide polymer is coated on the surface of a substrate, and is formed after heat treatment and alignment treatment.
液晶配向劑通常是將聚合物組份溶解在溶劑中所調製成的液狀組合物,且該液狀組合物續被塗佈於基板上,經加熱以形成液晶配向膜。液晶配向劑所選用的溶劑必須可均勻溶解聚合物,通常使用例如N-甲基-2-吡咯烷酮或γ-丁內酯等非質子性極性溶劑。另外,為使液晶配向劑塗佈於基板時的塗佈性(印刷性)良好,可使用例如丁基溶纖劑(butyl cellosolve)等表面張力較低的有機溶劑,與非質子性極性溶劑併用(如日本公開特許特開2010-97188號公報及特開2010-156934號公報所記載)。The liquid crystal alignment agent is usually a liquid composition prepared by dissolving polymer components in a solvent, and the liquid composition is then coated on a substrate and heated to form a liquid crystal alignment film. The solvent selected for the liquid crystal alignment agent must be able to dissolve the polymer uniformly, and aprotic polar solvents such as N-methyl-2-pyrrolidone or γ-butyrolactone are usually used. In addition, in order to make the coating property (printability) of the liquid crystal aligning agent good when it is applied to the substrate, an organic solvent with low surface tension such as butyl cellosolve can be used in combination with an aprotic polar solvent (such as Japanese Laid-Open Patent Publication No. 2010-97188 and Japanese Patent Laid-Open No. 2010-156934).
近年來,液晶電視已逐步普及,生產線也逐漸大型化。以大型生產線來達成基板大型化,其優點在於可以從一個基板形成多個面板(panel),故可縮短處理時間、降低成本,並且能對應液晶顯示元件本身尺寸的大型化。另一方面,基板大型化的缺點則在於難以確保液晶配向劑大面積印刷的均勻性。特別是藉由已廣泛使用的膠印機(offset printing machine)形成大面積的膜時,易因液晶配向劑印刷不良而導致液晶配向膜的電性缺陷。In recent years, LCD TVs have gradually become popular, and production lines have gradually become larger. The advantage of using a large production line to increase the size of the substrate is that a plurality of panels can be formed from one substrate, so the processing time and cost can be shortened, and the size of the liquid crystal display element itself can be increased. On the other hand, the disadvantage of an enlarged substrate is that it is difficult to ensure the uniformity of the large-area printing of the liquid crystal aligning agent. In particular, when a large-area film is formed by a widely used offset printing machine, it is easy to cause electrical defects in the liquid crystal alignment film due to poor printing of the liquid crystal alignment agent.
為了克服上述問題,業界改以噴墨塗佈法形成液晶配向膜。噴墨塗佈法的優點在於印刷中使用的液晶配向劑與實際塗佈的液量大致相同,故預期可降低液晶配向劑的使用量。另外,由於不須使用印刷版,故可以降低維護(更換和清潔印刷版)所需的時間、勞力以及成本,並且具有可用於處理各種尺寸之面板的靈活性。In order to overcome the above-mentioned problems, the industry uses an inkjet coating method to form a liquid crystal alignment film. The advantage of the inkjet coating method is that the amount of liquid crystal alignment agent used in printing is approximately the same as the liquid amount actually applied, so it is expected that the amount of liquid crystal alignment agent used can be reduced. In addition, the time, labor, and cost required for maintenance (replacing and cleaning the printing plate) can be reduced because the printing plate does not need to be used, and the flexibility can be used to handle panels of various sizes.
因此,目前亟需提出一種液晶配向劑,其具有噴墨印刷塗佈性佳之優點,而可用於例如噴墨塗佈法,使所形成的液晶配向膜應用於液晶顯示元件時能有更良好的顯示品質。Therefore, there is an urgent need to provide a liquid crystal alignment agent, which has the advantages of good inkjet printing coating properties, and can be used in, for example, inkjet coating methods, so that the formed liquid crystal alignment film can have better performance when applied to liquid crystal display elements. Display quality.
本發明利用提供特殊之聚合物及溶劑而得到液晶配向劑,上述液晶配向劑具有噴墨印刷塗佈性佳之優點。The present invention obtains a liquid crystal aligning agent by providing a special polymer and a solvent, and the liquid crystal aligning agent has the advantage of good ink-jet printing coatability.
因此,本發明提供一種液晶配向劑,包含: 聚合物(A),係由包括四羧酸二酐組份(a)及二胺組份(b)的混合物反應所製得;及 溶劑(B),包含式(1)所示之化合物(B-1)、4,6-二甲基-2-庚酮(B-2)及2,6-二甲基-4-庚酮(B-3);式(1) 式(1)中,R1 為C2 至C12 之烷基。Therefore, the present invention provides a liquid crystal alignment agent, comprising: a polymer (A) prepared by reacting a mixture comprising a tetracarboxylic dianhydride component (a) and a diamine component (b); and a solvent (B) ), including compound (B-1), 4,6-dimethyl-2-heptanone (B-2) and 2,6-dimethyl-4-heptanone (B- 3); Formula (1) In formula (1), R 1 is a C 2 to C 12 alkyl group.
本發明另提供一種液晶配向膜,係由前述之液晶配向劑所形成。The present invention further provides a liquid crystal alignment film, which is formed by the aforementioned liquid crystal alignment agent.
本發明又提供一種液晶顯示元件,包含前述之液晶配向膜。The present invention further provides a liquid crystal display element comprising the aforementioned liquid crystal alignment film.
本發明又提供一種液晶配向膜的製造方法,係藉由噴墨印刷法使前述之液晶配向劑形成一液晶配向膜。The present invention further provides a method for manufacturing a liquid crystal alignment film, which is to form a liquid crystal alignment film from the aforementioned liquid crystal alignment agent by an inkjet printing method.
本發明提供一種液晶配向劑,包含: 聚合物(A),係由包括四羧酸二酐組份(a)及二胺組份(a)的混合物反應所製得;及 溶劑(B),包含式(1)所示之化合物(B-1)、4,6-二甲基-2-庚酮(B-2)及2,6-二甲基-4-庚酮(B-3);式(1) 式(1)中,R1 為C2 至C12 之烷基。The present invention provides a liquid crystal alignment agent, comprising: a polymer (A) prepared by reacting a mixture comprising a tetracarboxylic dianhydride component (a) and a diamine component (a); and a solvent (B), Including compound (B-1) represented by formula (1), 4,6-dimethyl-2-heptanone (B-2) and 2,6-dimethyl-4-heptanone (B-3) ; Formula (1) In formula (1), R 1 is a C 2 to C 12 alkyl group.
本發明另提供一種液晶配向膜,係由前述之液晶配向劑所形成。The present invention further provides a liquid crystal alignment film, which is formed by the aforementioned liquid crystal alignment agent.
本發明之聚合物(A),係由包括四羧酸二酐組份(a)及二胺組份(b)的混合物反應所製得。具體而言,該聚合物(A)可選自聚醯胺酸聚合物、聚醯亞胺聚合物、聚醯亞胺系嵌段共聚合物或上述聚合物的任意組合。其中,聚醯亞胺系嵌段共聚合物是選自聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物或上述聚合物的任意組合。The polymer (A) of the present invention is prepared by reacting a mixture comprising the tetracarboxylic dianhydride component (a) and the diamine component (b). Specifically, the polymer (A) can be selected from a polyimide polymer, a polyimide polymer, a polyimide-based block copolymer, or any combination of the aforementioned polymers. Wherein, the polyimide block copolymer is selected from the group consisting of polyimide block copolymer, polyimide block copolymer, polyimide-polyimide block copolymer or Any combination of the above polymers.
該四羧酸二酐組份(a)包括脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物、芳香族四羧酸二酐化合物、由式(a-1)至式(a-6)表示的四羧酸二酐化合物中的至少一種,或上述化合物的組合。The tetracarboxylic dianhydride component (a) includes aliphatic tetracarboxylic dianhydride compounds, alicyclic tetracarboxylic dianhydride compounds, aromatic tetracarboxylic dianhydride compounds, from formula (a-1) to formula ( At least one of the tetracarboxylic dianhydride compounds represented by a-6), or a combination of the above compounds.
該脂肪族四羧酸二酐化合物的具體例可包括但不限於乙烷四羧酸二酐(ethane tetracarboxylic dianhydride)、丁烷四羧酸二酐(butane tetracarboxylic dianhydride)或上述化合物的組合。Specific examples of the aliphatic tetracarboxylic dianhydride compound may include, but are not limited to, ethane tetracarboxylic dianhydride, butane tetracarboxylic dianhydride, or a combination of the above compounds.
該脂環族四羧酸二酐化合物的具體例可包括但不限於1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、順式-3,7-二丁基環庚基-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、二環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐或上述化合物的組合。Specific examples of the alicyclic tetracarboxylic dianhydride compound may include, but are not limited to, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4 -Cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4- Cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetra Carboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutyl cycloheptyl-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic acid dianhydride, bicyclo[2.2.2]-octane -7-ene-2,3,5,6-tetracarboxylic dianhydride or a combination of the above.
該芳香族四羧酸二酐化合物的具體例可包括但不限於3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3’-4,4’-二苯基乙烷四羧酸二酐、3,3’,4,4’-二甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯硫醚二酐、4,4’-雙(3,4-二羧基苯氧基)二苯碸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯丙烷二酐(4,4’-bis(3,4-dicarboxy phenoxy)diphenylpropane dianhydride)、3,3’,4,4’-全氟異亞丙基二苯二酸二酐、3,3’,4,4’-二苯基四羧酸二酐、雙(苯二酸)苯膦氧化物二酐、對-伸苯基-雙(三苯基苯二酸)二酐、間-伸苯基-雙(三苯基苯二酸)二酐、雙(三苯基苯二酸)-4,4’-二苯基醚二酐、雙(三苯基苯二酸)-4,4’-二苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、2,3,4,5-四氫呋喃四羧酸二酐、1,3,3a,4,5,9b-六氫-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮{(1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)naphtho[1,2-c]furan-1,3-dione)}、1,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5,8-二甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃基)-3-甲基-3-環己烯-1,2-二羧酸二酐等芳香族四羧酸二酐化合物或上述化合物的組合。Specific examples of the aromatic tetracarboxylic dianhydride compound may include, but are not limited to, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride , 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 1,4,5,8-naphthalene tetra Carboxylic dianhydride, 2,3,6,7-naphthalene tetracarboxylic dianhydride, 3,3'-4,4'-diphenylethane tetracarboxylic dianhydride, 3,3',4,4' -Dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3',4,4'-tetraphenylsilane tetracarboxylic dianhydride, 1,2,3,4-furan tetracarboxylic dianhydride, 4 ,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylene dianhydride, 4,4' -Bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride (4,4'-bis(3,4-dicarboxy phenoxy)diphenylpropane dianhydride), 3,3',4,4'-perfluoroiso Propylene diphthalic dianhydride, 3,3',4,4'-diphenyltetracarboxylic dianhydride, bis(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis( Triphenylphthalic acid) dianhydride, m-phenylene-bis (triphenylphthalic acid) dianhydride, bis (triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, Bis(triphenylphthalic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol-bis(anhydrotrimellitate), propylene glycol-bis(anhydrotrimellitate), 1, 4-Butanediol-bis(anhydrotrimellitate), 1,6-hexanediol-bis(anhydrotrimellitate), 1,8-octanediol-bis(anhydrotrimellitate) ), 2,2-bis(4-hydroxyphenyl)propane-bis(anhydrotrimellitate), 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3a,4,5 ,9b-Hexahydro-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione{(1,3 ,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)naphtho[1,2-c]furan-1,3-dione)}, 1,3,3a, 4,5,9b-Hexahydro-5-methyl-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1,2-c]-furan-1,3 -diketone, 1,3,3a,4,5,9b-hexahydro-5-ethyl-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1, 2-c]-Furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-methyl-5-(tetrahydro-2,5-dioxy-3 -furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-ethyl-5-(tetrahydro- 2,5-Di-oxy-3-furyl)-naphtho [1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxygen yl-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5-( Tetrahydro-2,5-dioxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexa Hydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, Aromatic tetracarboxylic dianhydride compounds such as 5-(2,5-di-oxytetrahydrofuranyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic acid dianhydride, or combinations thereof.
由式(a-1)至式(a-6)表示的四羧酸二酐化合物如下所示:式(a-1)式(a-2)式(a-3)式(a-4)式(a-5) 式(a-5)中,A1 表示含有芳香環的二價基團;r表示1至2的整數;A2 及A3 可為相同或不同,且可各自獨立表示-H或烷基。由式(a-5)表示的四羧酸二酐化合物的具體例包括由式(a-5-1)至式(a-5-3)表示的化合物中的至少一種。式(a-5-1)式(a-5-2)式(a-5-3)式(a-6) 式(a-6)中,A4 表示含有芳香環的二價基團;A5 及A6 可為相同或不同,且各自獨立表示-H或烷基。由式(a-6)表示的四羧酸二酐化合物較佳為由式(a-6-1)表示的化合物。式(a-6-1)The tetracarboxylic dianhydride compounds represented by formula (a-1) to formula (a-6) are shown below: Formula (a-1) Formula (a-2) Formula (a-3) Formula (a-4) Formula (a-5) In formula (a-5), A 1 represents a divalent group containing an aromatic ring; r represents an integer of 1 to 2; A 2 and A 3 may be the same or different, and may each independently represent -H or alkyl. Specific examples of the tetracarboxylic dianhydride compound represented by formula (a-5) include at least one of the compounds represented by formula (a-5-1) to formula (a-5-3). Formula (a-5-1) Formula (a-5-2) Formula (a-5-3) Formula (a-6) In formula (a-6), A 4 represents a divalent group containing an aromatic ring; A 5 and A 6 may be the same or different, and each independently represents -H or an alkyl group. The tetracarboxylic dianhydride compound represented by formula (a-6) is preferably a compound represented by formula (a-6-1). Formula (a-6-1)
較佳地,四羧酸二酐組份(a)包含但不限於1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、1,2,4,5-環己烷四羧酸二酐、3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐以及3,3’,4,4’-聯苯碸四羧酸二酐。四羧酸二酐組份(a)可以單獨使用或者組合多種來使用。Preferably, the tetracarboxylic dianhydride component (a) includes but is not limited to 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic acid di- Anhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,4-dicarboxy-1,2,3,4-tetra Hydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride and 3,3',4,4'-biphenyl Tetracarboxylic dianhydride. The tetracarboxylic dianhydride component (a) may be used alone or in combination of two or more.
該二胺組份(b)包括脂肪族二胺化合物、脂環族二胺化合物、芳香族二胺化合物、由式(b-1)至式(b-26)表示的二胺化合物、或其組合。The diamine component (b) includes an aliphatic diamine compound, an alicyclic diamine compound, an aromatic diamine compound, a diamine compound represented by formula (b-1) to formula (b-26), or its combination.
該脂肪族二胺化合物的具體例包括但不限於1,2-二胺基乙烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4’-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷,或上述化合物的組合。Specific examples of the aliphatic diamine compound include, but are not limited to, 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane Alkane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10-diaminodecane Alkane, 4,4'-diaminoheptane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1, 7-Diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1 ,9-Diamino-5-methylnonane, 2,11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis(3-aminopropoxy) Ethane, or a combination of the above.
該脂環族二胺化合物的具體例包括但不限於4,4’-二胺基二環己基甲烷、4,4’-二胺基-3,3’-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、三環[6.2.1.02,7]-十一碳烯二甲基二胺、4,4’-亞甲基雙(環己基胺),或上述化合物的組合。Specific examples of the alicyclic diamine compound include, but are not limited to, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethyldicyclohexylamine, 1 ,3-diaminocyclohexane, 1,4-diaminocyclohexane, isophorone diamine, tetrahydrodicyclopentadiene diamine, tricyclo[6.2.1.02,7]-undecane Carbendimethyldiamine, 4,4'-methylenebis(cyclohexylamine), or a combination of the foregoing.
該芳香族二胺化合物的具體例包括但不限於4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基乙烷、4,4’-二胺基二苯基碸、4,4’-二胺基苯甲醯苯胺、4,4’-二胺基二苯基醚、3,4’-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、6-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、六氫-4,7-甲橋伸氫茚基二亞甲基二胺、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、9,10-雙(4-胺基苯基)蒽[9,10-bis(4-aminophenyl) anthracene]、2,7-二胺基茀、9,9-雙(4-胺基苯基)茀、4,4’-亞甲基-雙(2-氯苯胺)、4,4’-(對-伸苯基異亞丙基)雙苯胺、4,4’-(間-伸苯基異亞丙基)雙苯胺、2,2’-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4’-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、5-[4-(4-正戊烷基環己基)環己基]苯基-亞甲基-1,3-二胺基苯{5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl) cyclohexane},或上述化合物的組合。Specific examples of the aromatic diamine compound include, but are not limited to, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenyl Base, 4,4'-diaminobenzylaniline, 4,4'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene , 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, 6-amino-1-(4'-aminophenyl)-1,3 ,3-Trimethylhydroindene, Hexahydro-4,7-methylhydroindenyl dimethylenediamine, 3,3'-diaminobenzophenone, 3,4'-diamino Benzophenone, 4,4'-Diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4 -Aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenoxy)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl ] bismuth, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene , 9,9-bis(4-aminophenyl)-10-hydroanthracene, 9,10-bis(4-aminophenyl) anthracene [9,10-bis(4-aminophenyl) anthracene], 2, 7-Diamino fluoride, 9,9-bis(4-aminophenyl) fluoride, 4,4'-methylene-bis(2-chloroaniline), 4,4'-(p-phenylene Isopropylidene) bisaniline, 4,4'-(m-phenylene isopropylidene) bisaniline, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy] base)phenyl]hexafluoropropane, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, 5-[4-(4-n-pentane cyclohexyl)cyclohexyl]phenyl-methylene-1,3-diaminobenzene{5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}, 1,1- Bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane{1,1-bis[4-(4-aminophenoxy)phenyl]-4-( 4-ethylphenyl)cyclohexane}, or a combination of the above.
由式(b-1)表示的二胺化合物如下所示:式(b-1) 式(b-1)中,B1 表示、、、、,或; B表示具有甾(膽固醇(steroid))骨架的基、三氟甲基、氟基、碳數為2至30的烷基、或衍生自吡啶、嘧啶、三嗪、哌啶或哌嗪等含氮原子環狀結構的一價基團。The diamine compound represented by formula (b-1) is shown below: Formula (b-1) In formula (b-1), B 1 represents , , , , ,or ; B represents a group with a steroid (steroid) skeleton, a trifluoromethyl group, a fluoro group, an alkyl group with a carbon number of 2 to 30, or a group derived from pyridine, pyrimidine, triazine, piperidine or piperazine containing A monovalent group of a ring structure of nitrogen atoms.
由式(b-1)表示的化合物的具體例包括但不限於2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethyl formate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5- diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diaminobenzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)、由式(b-1-1)至式(b-1-6)表示的化合物中的至少其中一種,或上述化合物的組合。Specific examples of the compound represented by formula (b-1) include, but are not limited to, 2,4-diaminophenyl ethyl formate, 3,5-diaminophenyl ethyl formate Ester (3,5-diaminophenyl ethyl formate), 2,4-diaminophenyl propyl formate (2,4-diaminophenyl propyl formate), 3,5-diaminophenyl propyl formate (3,5-diaminophenyl propyl formate) diaminophenyl propyl formate), 1-dodecoxy-2,4-diaminobenzene (1-dodecoxy-2,4-diaminobenzene), 1-hexadecoxy-2,4-diaminobenzene ( 1-hexadecoxy-2,4-diaminobenzene), 1-octadecoxy-2,4-diaminobenzene (1-octadecoxy-2,4-diaminobenzene), from formula (b-1-1) to formula At least one of the compounds represented by (b-1-6), or a combination of the above compounds.
由式(b-1-1)至式(b-1-6)表示的化合物如下所示:式(b-1-1)式(b-1-2)式(b-1-3)式(b-1-4)式(b-1-5)式(b-1-6)The compounds represented by formula (b-1-1) to formula (b-1-6) are shown below: Formula (b-1-1) Formula (b-1-2) Formula (b-1-3) Formula (b-1-4) Formula (b-1-5) Formula (b-1-6)
由式(b-2)表示的二胺化合物如下所示:式(b-2) 式(b-2)中,B1 與式(b-1)中的B1 相同,B3 及B4 各自獨立表示二價脂肪族環、二價芳香族環或二價雜環基團; B5 表示碳數為3至18的烷基、碳數為3至18的烷氧基、碳數為1至5的氟烷基、碳數為1至5的氟烷氧基、氰基或鹵素原子。The diamine compound represented by the formula (b-2) is shown below: Formula (b-2) In formula (b-2), B 1 is the same as B 1 in formula (b-1), and B 3 and B 4 each independently represent a divalent aliphatic ring, a divalent aromatic ring, or a divalent aromatic ring. Valence heterocyclic group; B 5 represents an alkyl group with a carbon number of 3 to 18, an alkoxy group with a carbon number of 3 to 18, a fluoroalkyl group with a carbon number of 1 to 5, and a fluoroalkane with a carbon number of 1 to 5 oxy, cyano or halogen atom.
由式(b-2)表示的化合物的具體例包括由下列式(b-2-1)至式(b-2-13)表示的化合物中的至少其中一種:式(b-2-1)式(b-2-2)式(b-2-3)式(b-2-4)式(b-2-5)式(b-2-6)式(b-2-7)式(b-2-8)式(b-2-9)式(b-2-10)式(b-2-11)式(b-2-12)式(b-2-13) 式(b-2-1)至式(b-2-13)中,s表示3至12的整數。Specific examples of the compound represented by the formula (b-2) include at least one of the compounds represented by the following formulas (b-2-1) to (b-2-13): Formula (b-2-1) Formula (b-2-2) Formula (b-2-3) Formula (b-2-4) Formula (b-2-5) Formula (b-2-6) Formula (b-2-7) Formula (b-2-8) Formula (b-2-9) Formula (b-2-10) Formula (b-2-11) Formula (b-2-12) Formula (b-2-13) In formula (b-2-1) to formula (b-2-13), s represents an integer of 3 to 12.
由式(b-3)表示的二胺化合物如下所示:式(b-3) 式(b-3)中,B6 各自獨立表示氫原子、碳數為1至5的醯基、碳數為1至5的烷基、碳數為1至5的烷氧基或鹵素原子,且每個重複單元中的B6 可為相同或不同; u表示1至3的整數。The diamine compound represented by the formula (b-3) is shown below: Formula (b-3) In formula (b-3), B 6 each independently represents a hydrogen atom, an acyl group having 1 to 5 carbon atoms, an alkyl group having 1 to 5 carbon atoms, and an alkane having 1 to 5 carbon atoms. an oxy group or a halogen atom, and B 6 in each repeating unit may be the same or different; u represents an integer of 1 to 3.
由式(b-3)表示的化合物的具體例包括當u為1時:對-二胺苯、間-二胺苯、鄰-二胺苯或2,5-二胺基甲苯等;當u為2時:4,4’-二胺基聯苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基聯苯、3,3’-二氯-4,4’-二胺基聯苯、2,2’,5,5’-四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基聯苯或4,4’-二胺基-2,2’-雙(三氟甲基)聯苯等;或當u為3時:1,4-雙(4’-胺基苯基)苯等。Specific examples of the compound represented by the formula (b-3) include when u is 1: p-diaminebenzene, m-diaminebenzene, o-diaminebenzene or 2,5-diaminotoluene, etc.; when u is When it is 2: 4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diphenyl Aminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diaminobiphenyl, 3,3'- Dichloro-4,4'-diaminobiphenyl, 2,2',5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4' -Diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, etc.; or when u is 3: 1 , 4-bis(4'-aminophenyl)benzene, etc.
由式(b-3)表示的化合物的具體例較佳為包括對-二胺苯、2,5-二胺基甲苯、4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、1,4-雙(4’-胺基苯基)苯或上述化合物的組合。Specific examples of the compound represented by formula (b-3) preferably include p-diaminobenzene, 2,5-diaminotoluene, 4,4'-diaminobiphenyl, 3,3'-dimethylbenzene Oxy-4,4'-diaminobiphenyl, 1,4-bis(4'-aminophenyl)benzene, or a combination of the foregoing.
由式(b-4)表示的二胺化合物如下所示:式(b-4) 式(b-4)中,v表示2至12的整數。The diamine compound represented by the formula (b-4) is shown below: Formula (b-4) In formula (b-4), v represents an integer of 2 to 12.
由式(b-5)表示的二胺化合物如下所示:式(b-5) 式(b-5)中,w表示1至5的整數。The diamine compound represented by the formula (b-5) is shown below: Formula (b-5) In formula (b-5), w represents an integer of 1 to 5.
由式(b-5)表示的化合物較佳為4,4’-二胺基-二苯基硫醚。The compound represented by formula (b-5) is preferably 4,4'-diamino-diphenyl sulfide.
由式(b-6)表示的二胺化合物如下所示:式(b-6) 式(b-6)中,B7 及B9 各自獨立表示二價有機基團,且B7 及B9 可為相同或不同; B8 表示衍生自吡啶、嘧啶、三嗪、哌啶或哌嗪等含氮原子的環狀結構的二價基團。The diamine compound represented by the formula (b-6) is shown below: Formula (b-6) In formula (b-6), B 7 and B 9 each independently represent a divalent organic group, and B 7 and B 9 may be the same or different; B 8 represents derived from pyridine, pyrimidine, trivalent Divalent groups of cyclic structures containing nitrogen atoms such as oxazine, piperidine or piperazine.
由式(b-7)表示的二胺化合物如下所示:式(b-7) 式(b-7)中,B10 、B11 、B12 及B13 各自獨立表示碳數為1至12的烴基,且B10 、B11 、B12 及B13 可為相同或不同; x1各自獨立表示1至3的整數;及 x2表示1至20的整數。The diamine compound represented by the formula (b-7) is shown below: Formula (b-7) In formula (b-7), B 10 , B 11 , B 12 and B 13 each independently represent a hydrocarbon group having 1 to 12 carbon atoms, and B 10 , B 11 , B 12 and B 13 may be are the same or different; x1 each independently represents an integer from 1 to 3; and x2 represents an integer from 1 to 20.
由式(b-8)表示的二胺化合物如下所示:式(b-8) 式(b-8)中,B14 表示氧原子或伸環己烷基; B15 表示亞甲基; B16 表示伸苯基或伸環己烷基;及 B17 表示氫原子或庚基。The diamine compound represented by the formula (b-8) is shown below: Formula (b-8) In formula (b-8), B 14 represents an oxygen atom or a cyclohexylene group; B 15 represents a methylene group; B 16 represents a phenylene group or a cyclohexylene group; and B 17 represents hydrogen atom or heptyl group.
由式(b-8)表示的化合物的具體例包括由式(b-8-1)表示的化合物、由式(b-8-2)表示的化合物或上述化合物的組合:式(b-8-1)式(b-8-2)Specific examples of the compound represented by the formula (b-8) include the compound represented by the formula (b-8-1), the compound represented by the formula (b-8-2), or a combination of the above compounds: Formula (b-8-1) Formula (b-8-2)
由式(b-9)至式(b-25)表示的化合物如下所示:式(b-9)式(b-10)式(b-11)式(b-12)式(b-13)式(b-14)式(b-15)式(b-16)式(b-17)式(b-18)式(b-19)式(b-20)式(b-21)式(b-22)式(b-23)式(b-24)式(b-25) 式(b-17)至式(b-25)中,B18 較佳為表示碳數為1至10的烷基或碳數為1至10的烷氧基;B19 較佳為表示氫原子、碳數為1至10的烷基或碳數為1至10的烷氧基。The compounds represented by formula (b-9) to formula (b-25) are shown below: Formula (b-9) Formula (b-10) Formula (b-11) Formula (b-12) Formula (b-13) Formula (b-14) Formula (b-15) Formula (b-16) Formula (b-17) Formula (b-18) Formula (b-19) Formula (b-20) Formula (b-21) Formula (b-22) Formula (b-23) Formula (b-24) Formula (b-25) In formula (b-17) to formula (b-25), B 18 preferably represents an alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms; B 19 Preferably, it represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10 carbon atoms.
式(b-26) 式(b-26)中,B0 、B2 分別獨立表示單鍵、-O-、-COO-或-OCO-;B1 為碳數為1至3的伸烷基;B3 為單鍵或碳數為1至3的伸烷基。d與g各自獨立表示0或1;e表示0至2的整數;f表示1至20的整數;其中d與e不同時為0。 Formula (b-26) In formula (b-26), B 0 and B 2 each independently represent a single bond, -O-, -COO- or -OCO-; B 1 is an alkylene group having 1 to 3 carbon atoms ; B 3 is a single bond or an alkylene group with 1 to 3 carbon atoms. d and g each independently represent 0 or 1; e represents an integer from 0 to 2; f represents an integer from 1 to 20; wherein d and e are not 0 at the same time.
式(b-26)中,以「-B0 -(B1 -B2 )g -」表示的二價基團較佳為碳數為1至3的伸烷基、*-O-、*-COO-或*-O-C2 H4 -O-(其中,*表示與二胺基苯基鍵結的鍵結處。)。以「-Cf H2f+1 」表示的基團較佳為直鏈狀。二胺基苯基中的兩個胺基,相對於其他基團的位置較佳為2,4位或3,5位。In formula (b-26), the divalent group represented by "-B 0 -(B 1 -B 2 ) g -" is preferably an alkylene group having 1 to 3 carbon atoms, *-O-, * -COO- or *-OC 2 H 4 -O- (wherein, * represents a bond with a diaminophenyl group.). The group represented by "-C f H 2f+1 " is preferably linear. The positions of the two amine groups in the diaminophenyl group are preferably 2, 4 or 3, 5 with respect to other groups.
由式(b-26)表示的化合物的具體例可列舉由下列式(b-26-1)至式(b-26-4)表示的化合物:式(b-26-1)式(b-26-2)式(b-26-3)式(b-26-4)Specific examples of the compound represented by the formula (b-26) include compounds represented by the following formulae (b-26-1) to (b-26-4): Formula (b-26-1) Formula (b-26-2) Formula (b-26-3) Formula (b-26-4)
該二胺組份(b)可單獨使用或組合多種來使用。The diamine component (b) can be used alone or in combination.
該二胺組份(b)的具體例較佳為包括但不限於1,2-二胺基乙烷、4,4’-二胺基二環己基甲烷、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷、2,4-二胺基苯基甲酸乙酯、1-十八烷氧基-2,4-二胺基苯、由式(b-1-1)表示的化合物、由式(b-1-2)表示的化合物、由式(b-2-1)表示的化合物、由式(b-2-11)表示的化合物、對-二胺苯、間-二胺苯、鄰-二胺苯、由式(b-8-1)表示的化合物,或上述化合物的組合。Specific examples of the diamine component (b) preferably include, but are not limited to, 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diaminodicyclohexane Phenylmethane, 4,4'-diaminodiphenyl ether, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene, 1,1-Bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane, 2,4-diaminophenylcarboxylate, 1- Octadecyloxy-2,4-diaminobenzene, compound represented by formula (b-1-1), compound represented by formula (b-1-2), compound represented by formula (b-2-1) The compound represented by the formula (b-2-11), p-diaminebenzene, m-diaminebenzene, o-diaminebenzene, the compound represented by the formula (b-8-1), or the above combination of compounds.
該聚合物(A)可包括聚醯胺酸及聚醯亞胺中的至少一者。另外,聚合物(A)可更包括聚醯亞胺系嵌段共聚合物。以下進一步說明上述各種聚合組成物的製備方法。The polymer (A) may include at least one of polyamic acid and polyimide. In addition, the polymer (A) may further include a polyimide-based block copolymer. The preparation methods of the above-mentioned various polymer compositions are further described below.
製備聚醯胺酸的方法為先將混合物溶解於溶劑中,其中混合物包括四羧酸二酐組份(a)與二胺組份(b),並於0°C至100°C的溫度下進行聚縮合反應。反應1小時至24小時後,以蒸發器對反應溶液進行減壓蒸餾,即可得到聚醯胺酸。或者,將反應溶液倒入大量的貧溶劑中,以得到析出物。接著,以減壓乾燥的方式乾燥析出物,即可得到聚醯胺酸。The method for preparing polyamic acid is to first dissolve the mixture in a solvent, wherein the mixture includes a tetracarboxylic dianhydride component (a) and a diamine component (b), and the mixture is heated at a temperature of 0 ° C to 100 ° C. A polycondensation reaction is carried out. After 1 hour to 24 hours of reaction, the reaction solution is distilled under reduced pressure with an evaporator to obtain polyamic acid. Alternatively, the reaction solution is poured into a large amount of lean solvent to obtain a precipitate. Next, the precipitate is dried under reduced pressure to obtain a polyamide acid.
基於該二胺組份(b)之使用量為100莫耳,該四羧酸二酐組份(a)之使用量為20莫耳至200莫耳;更佳地,該四羧酸二酐組份(a)之使用量為30莫耳至120莫耳。Based on 100 mol of the diamine component (b), the used amount of the tetracarboxylic dianhydride component (a) is 20 mol to 200 mol; more preferably, the tetracarboxylic dianhydride Component (a) is used in an amount of 30 mol to 120 mol.
用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑相同或不同,且用於聚縮合反應中的溶劑並無特別的限制,只要是可溶解反應物與生成物即可。溶劑較佳為包括但不限於(1)非質子系極性溶劑,例如:N-甲基-2-吡咯烷酮(N-methyl-2- pyrrolidinone;NMP)、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞碸、γ-丁內酯、四甲基尿素或六甲基磷酸三胺等的非質子系極性溶劑;或(2)酚系溶劑,例如:間-甲酚、二甲苯酚、酚或鹵化酚類等的酚系溶劑。基於混合物的總使用量為100重量份,用於聚縮合反應中的溶劑之使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。The solvent used in the polycondensation reaction may be the same as or different from the solvent used in the liquid crystal aligning agent described below, and the solvent used in the polycondensation reaction is not particularly limited as long as it can dissolve the reactant and the product. The solvent preferably includes but is not limited to (1) aprotic polar solvents, such as: N-methyl-2-pyrrolidinone (N-methyl-2-pyrrolidinone; NMP), N,N-dimethylacetamide, Aprotic polar solvents such as N,N-dimethylformamide, dimethylsulfoxide, γ-butyrolactone, tetramethylurea or hexamethylphosphoric triamine; or (2) phenolic solvents, For example, phenolic solvents such as m-cresol, xylenol, phenol, and halogenated phenols. The solvent used in the polycondensation reaction is preferably used in an amount of 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight, based on 100 parts by weight of the total mixture.
值得注意的是,於聚縮合反應中,溶劑可併用適量的貧溶劑,其中貧溶劑不會造成聚醯胺酸析出。貧溶劑可以使用單獨一種或者組合多種來使用,且其包括但不限於(1)醇類,例如:甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇或三乙二醇等的醇類;(2)酮類,例如:丙酮、甲基乙基酮、甲基異丁基酮、環己酮等的酮類;(3)酯類,例如:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯或乙二醇乙基醚醋酸酯等的酯類;(4)醚類,例如:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚或二乙二醇二甲基醚等的醚類;(5)鹵化烴類,例如:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯或鄰-二氯苯等的鹵化烴類;或(6)烴類,例如:四氫呋喃、己烷、庚烷、辛烷、苯、甲苯或二甲苯等的烴類或上述溶劑的任意組合。基於二胺組份(b)之使用量為100重量份,該貧溶劑的用量較佳為0重量份至60重量份,且更佳為0重量份至50重量份。It is worth noting that in the polycondensation reaction, the solvent can be used in combination with an appropriate amount of poor solvent, wherein the poor solvent will not cause the precipitation of polyamide acid. The poor solvent can be used alone or in combination, and it includes but is not limited to (1) alcohols, such as methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol Alcohols such as alcohol or triethylene glycol; (2) ketones, such as: ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.; (3) esters, such as: Esters of methyl acetate, ethyl acetate, butyl acetate, diethyl oxalate, diethyl malonate or ethylene glycol ethyl ether acetate; (4) ethers, such as diethyl ether, Ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether ethers such as base ethers; (5) halogenated hydrocarbons, such as dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene or o-dichloromethane Halogenated hydrocarbons such as benzene; or (6) hydrocarbons, for example: hydrocarbons such as tetrahydrofuran, hexane, heptane, octane, benzene, toluene or xylene, or any combination of the above solvents. The amount of the lean solvent used is preferably 0 to 60 parts by weight, and more preferably 0 to 50 parts by weight, based on 100 parts by weight of the diamine component (b).
製備聚醯亞胺的方法為將上述製備聚醯胺酸的方法所製的聚醯胺酸在脫水劑及觸媒的存在下進行加熱而得。在加熱過程中,聚醯胺酸中的醯胺酸官能基可經由脫水閉環反應轉變成醯亞胺官能基(即醯亞胺化)。The method for preparing polyimide is obtained by heating the polyamic acid prepared by the above-mentioned method for preparing polyamic acid in the presence of a dehydrating agent and a catalyst. During the heating process, the aramidic acid functional group in the polyamic acid can be converted into an imidimine functional group via a dehydration ring-closure reaction (ie, imidization).
用於脫水閉環反應中的溶劑可與液晶配向劑中的溶劑(B)相同,故在此不另贅述。基聚醯胺酸之使用量為100重量份,用於脫水閉環反應中的溶劑之使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。The solvent used in the dehydration ring-closing reaction can be the same as the solvent (B) in the liquid crystal alignment agent, so it is not repeated here. The amount of the base polyamide used is 100 parts by weight, and the amount of the solvent used in the dehydration ring-closure reaction is preferably 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight.
為獲得較佳的聚醯胺酸的醯亞胺化程度,脫水閉環反應的操作溫度較佳為40°C至200°C,更佳為40°C至150°C。若脫水閉環反應的操作溫度低於40°C時,醯亞胺化的反應不完全,而降低聚醯胺酸的醯亞胺化程度。然而,若脫水閉環反應的操作溫度高於200°C時,所得的聚醯亞胺的重量平均分子量偏低。In order to obtain a better degree of imidization of the polyamic acid, the operating temperature of the dehydration ring-closure reaction is preferably 40°C to 200°C, more preferably 40°C to 150°C. If the operating temperature of the dehydration ring-closure reaction is lower than 40° C., the imidization reaction is not complete, and the degree of imidization of the polyamic acid is reduced. However, if the operating temperature of the dehydration ring-closure reaction is higher than 200°C, the weight-average molecular weight of the obtained polyimide is low.
用於脫水閉環反應中的脫水劑可選自於酸酐類化合物,其具體例如:醋酸酐、丙酸酐或三氟醋酸酐等的酸酐類化合物。基於聚醯胺酸為1莫耳,脫水劑之使用量為0.01莫耳至20莫耳。用於脫水閉環反應中的觸媒可選自於(1)吡啶類化合物,例如:吡啶、三甲基吡啶或二甲基吡啶等的吡啶類化合物;(2)三級胺類化合物,例如:三乙基胺等的三級胺類化合物。基於脫水劑之使用量為1莫耳,觸媒之使用量可為0.5莫耳至10莫耳。The dehydrating agent used in the dehydration ring-closure reaction can be selected from acid anhydride compounds, such as acid anhydride compounds such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride. The amount of the dehydrating agent used is 0.01 mol to 20 mol based on 1 mol of the polyamide. The catalyst used in the dehydration ring-closure reaction can be selected from (1) pyridine compounds, such as: pyridine compounds such as pyridine, collidine or lutidine; (2) tertiary amine compounds, such as: Tertiary amine compounds such as triethylamine. Based on 1 mol of the dehydrating agent, the used amount of the catalyst may be 0.5 mol to 10 mol.
於本發明之具體例中,該聚合物組成物(A)的醯亞胺化率為30%至90%,較佳為35%至85%,更佳為40%至80%。當聚合物組成物(A)的醯亞胺化率介於上述之範圍時,則所得之液晶配向劑的噴墨印刷塗佈性較佳。In a specific example of the present invention, the imidization rate of the polymer composition (A) is 30% to 90%, preferably 35% to 85%, more preferably 40% to 80%. When the imidization ratio of the polymer composition (A) is within the above-mentioned range, the obtained liquid crystal aligning agent has better ink jet printing coatability.
聚醯亞胺系嵌段共聚合物為選自聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物或上述聚合物的任意組合。The polyimide block copolymer is selected from the group consisting of polyimide block copolymer, polyimide block copolymer, polyimide-polyimide block copolymer or the above-mentioned polymerization any combination of things.
製備聚醯亞胺系嵌段共聚合物的方法較佳為先將起始物溶解於溶劑中,並進行聚縮合反應,其中起始物包括至少一種聚醯胺酸及/或至少一種聚醯亞胺,且可進一步包括四羧酸二酐組份(a)與二胺組份(b)。The method for preparing the polyimide-based block copolymer is preferably to first dissolve the starting material in a solvent and carry out a polycondensation reaction, wherein the starting material includes at least one polyamide acid and/or at least one polyamide imine, and may further include a tetracarboxylic dianhydride component (a) and a diamine component (b).
起始物中的四羧酸二酐組份與二胺組份可與製備聚醯胺酸的方法中所使用的四羧酸二酐組份(a)與二胺組份(b)相同,且用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑(B)相同,在此不另贅述。The tetracarboxylic dianhydride component and the diamine component in the starting material can be the same as the tetracarboxylic dianhydride component (a) and the diamine component (b) used in the method for preparing polyamic acid, And the solvent used in the polycondensation reaction can be the same as the solvent (B) in the following liquid crystal alignment agent, which is not repeated here.
基於起始物之使用量為100重量份,用於聚縮合反應中的溶劑之使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。聚縮合反應的操作溫度較佳為0°C至200°C,且更佳為0°C至100°C。The solvent used in the polycondensation reaction is preferably used in an amount of 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight, based on 100 parts by weight of the starting material. The operating temperature of the polycondensation reaction is preferably 0°C to 200°C, and more preferably 0°C to 100°C.
起始物較佳為包括但不限於(1)二種末端基相異且結構相異的聚醯胺酸;(2)二種末端基相異且結構相異的聚醯亞胺;(3)末端基相異且結構相異的聚醯胺酸及聚醯亞胺;(4)聚醯胺酸、四羧酸二酐組份與二胺組份,其中,四羧酸二酐組份與二胺組份之中的至少一種與形成聚醯胺酸所使用的四羧酸二酐組份與二胺組份的結構相異;(5)聚醯亞胺、四羧酸二酐組份與二胺組份,其中,四羧酸二酐組份與二胺組份中的至少一種與形成聚醯亞胺所使用的四羧酸二酐組份與二胺組份的結構相異;(6)聚醯胺酸、聚醯亞胺、四羧酸二酐組份與二胺組份,其中,四羧酸二酐組份與二胺組份中的至少一種與形成聚醯胺酸或聚醯亞胺所使用的四羧酸二酐組份與二胺組份的結構相異;(7)二種結構相異的聚醯胺酸、四羧酸二酐組份與二胺組份;(8)二種結構相異的聚醯亞胺、四羧酸二酐組份與二胺組份;(9)二種末端基為酸酐基且結構相異的聚醯胺酸以及二胺組份;(10)二種末端基為胺基且結構相異的聚醯胺酸以及四羧酸二酐組份;(11)二種末端基為酸酐基且結構相異的聚醯亞胺以及二胺組份;或者(12)二種末端基為胺基且結構相異的聚醯亞胺以及四羧酸二酐組份。The starting materials preferably include but are not limited to (1) two kinds of polyamides with different end groups and different structures; (2) two kinds of polyimides with different end groups and different structures; (3) ) Polyamic acid and polyimide with different end groups and different structures; (4) Polyamic acid, tetracarboxylic dianhydride component and diamine component, among which, tetracarboxylic dianhydride component At least one of the diamine components is different in structure from the tetracarboxylic dianhydride component and the diamine component used to form the polyamide acid; (5) polyimide, tetracarboxylic dianhydride group component and diamine component, wherein, at least one of the tetracarboxylic dianhydride component and the diamine component is structurally different from the tetracarboxylic dianhydride component and the diamine component used to form the polyimide (6) polyamide acid, polyimide, tetracarboxylic dianhydride component and diamine component, wherein, at least one of the tetracarboxylic dianhydride component and the diamine component is combined with the formation of polyamide The tetracarboxylic dianhydride component and the diamine component used in the acid or polyimide have different structures; (7) two kinds of polyamide acid, tetracarboxylic dianhydride component and diamine with different structures components; (8) two kinds of polyimide, tetracarboxylic dianhydride component and diamine component with different structures; (9) two kinds of polyamide acids whose end groups are acid anhydride groups and different structures and Diamine component; (10) Two kinds of polyamide acid and tetracarboxylic dianhydride components whose end groups are amine groups and different structures; (11) Two kinds of polyamides whose end groups are acid anhydride groups and different structures imine and diamine components; or (12) two kinds of polyimide and tetracarboxylic dianhydride components whose terminal groups are amine groups and have different structures.
在不影響本發明的功效的範圍內,聚醯胺酸、聚醯亞胺以及聚醯亞胺系嵌段共聚合物較佳為先進行分子量調節後的末端修飾型聚合物。藉由使用末端修飾型的聚合物,可改善液晶配向劑的塗佈性能。製備末端修飾型聚合物的方式可藉由在聚醯胺酸進行聚縮合反應的同時,加入單官能性化合物來製得。In the range that does not affect the efficacy of the present invention, polyimide, polyimide and polyimide-based block copolymers are preferably terminal-modified polymers whose molecular weights are adjusted first. By using the terminal-modified polymer, the coating performance of the liquid crystal alignment agent can be improved. The method of preparing the terminal-modified polymer can be prepared by adding a monofunctional compound at the same time as the polyamide acid undergoes a polycondensation reaction.
單官能性化合物的具體例包括但不限於(1)一元酸酐,例如:馬來酸酐、鄰苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等一元酸酐;(2)單胺化合物,例如:苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、正十八烷胺或正二十烷胺等單胺化合物;或(3)單異氰酸酯化合物,例如:異氰酸苯酯或異氰酸萘基酯等單異氰酸酯化合物。Specific examples of monofunctional compounds include, but are not limited to (1) monobasic acid anhydrides such as maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecylsuccinic anhydride Monobasic acid anhydrides such as alkyl succinic anhydride or n-hexadecyl succinic anhydride; (2) monoamine compounds, such as: aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, n-decylamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, Monoamine compounds such as n-octadecylamine or n-eicosylamine; or (3) monoisocyanate compounds, for example: monoisocyanate compounds such as phenyl isocyanate or naphthyl isocyanate.
本發明的聚合物(A)根據凝膠滲透色層分析法(Gel Permeation Chromatography, GPC)所測得經聚苯乙烯換算的重量平均分子量為2000至200000,較佳為3000至100000,更佳為4000至50000。The polymer (A) of the present invention has a polystyrene-converted weight-average molecular weight of 2,000 to 200,000, preferably 3,000 to 100,000, as measured by Gel Permeation Chromatography (GPC). 4000 to 50000.
本發明之溶劑(B)包含式(1)所示之化合物(B-1)、4,6-二甲基-2-庚酮(B-2)及2,6-二甲基-4-庚酮(B-3);式(1) 式(1)中,R1 為C2 至C12 之烷基。The solvent (B) of the present invention contains the compound (B-1) represented by the formula (1), 4,6-dimethyl-2-heptanone (B-2) and 2,6-dimethyl-4- Heptanone (B-3); Formula (1) In formula (1), R 1 is a C 2 to C 12 alkyl group.
式(1)所示之化合物(B-1)中,R1 為C2 至C12 之烷基,例如乙基、異丙基、新丁基、異丁基等。亦即,式(1)所示之化合物(B-1)可為N-乙基-2-吡咯烷酮、N-異丙基-2-吡咯烷酮、N-新丁基-2-吡咯烷酮、N-異丁基-2-吡咯烷酮等。In the compound (B-1) represented by the formula (1), R 1 is an alkyl group of C 2 to C 12 , such as ethyl, isopropyl, neobutyl, isobutyl and the like. That is, the compound (B-1) represented by the formula (1) can be N-ethyl-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-neobutyl-2-pyrrolidone, N-isopropyl-2-pyrrolidone Butyl-2-pyrrolidone, etc.
基於該溶劑(B)的含量為100重量%,該式(1)所示之化合物(B-1)的含量通常為30重量%至80重量%;較佳為35重量%至75重量%;更佳為40重量%至70重量%。Based on the content of the solvent (B) being 100% by weight, the content of the compound (B-1) represented by the formula (1) is usually 30% by weight to 80% by weight; preferably 35% by weight to 75% by weight; More preferably, it is 40% by weight to 70% by weight.
此外,基於該溶劑(B)的含量為100重量%,該4,6-二甲基-2-庚酮(B-2)的含量通常為0.01重量%至10重量%;較佳為0.05重量%至10重量%;更佳為0.05重量%至8重量%。In addition, the content of the 4,6-dimethyl-2-heptanone (B-2) is usually 0.01 to 10% by weight based on 100% by weight of the solvent (B); preferably 0.05% by weight % to 10% by weight; more preferably 0.05% to 8% by weight.
再且,基於該溶劑(B)的含量為100重量%,該2,6-二甲基-4-庚酮(B-3)的含量通常為1重量%至20重量%;較佳為3重量%至20重量%;更佳為5重量%至20重量%。Furthermore, the content of the 2,6-dimethyl-4-heptanone (B-3) is usually 1 to 20% by weight based on 100% by weight of the solvent (B); preferably 3 % to 20% by weight; more preferably 5% to 20% by weight.
若該溶劑(B)未使用式(1)所示之化合物(B-1)、4,6-二甲基-2-庚酮(B-2)及2,6-二甲基-4-庚酮(B-3),則所製得之液晶配向劑之噴墨印刷塗佈性不佳。If the solvent (B) does not use the compound (B-1) represented by the formula (1), 4,6-dimethyl-2-heptanone (B-2) and 2,6-dimethyl-4- If heptanone (B-3) is used, the obtained liquid crystal alignment agent has poor inkjet printing coating properties.
較佳地,本發明之溶劑(B)更可包含醇類或二醇類化合物(B-4),該醇類或二醇類化合物(B-4)係選自由乙氧基乙醇、丁氧基乙醇、乙二醇、乙二醇單甲基醚、乙二醇單乙基醚、乙二醇單丙基醚、乙二醇單丁基醚或二甘醇所組成之群組。Preferably, the solvent (B) of the present invention may further comprise an alcohol or glycol compound (B-4), and the alcohol or glycol compound (B-4) is selected from ethoxyethanol, butoxy The group consisting of ethylene glycol, ethylene glycol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether or diethylene glycol.
基於該溶劑(B)的含量為100重量%,該醇類或二醇類化合物(B-4)的含量通常為15重量%至60重量%;較佳為20重量%至60重量%;更佳為25重量%至60重量%。Based on 100% by weight of the solvent (B), the content of the alcohol or glycol compound (B-4) is usually 15% to 60% by weight; preferably 20% to 60% by weight; more It is preferably 25% by weight to 60% by weight.
若該溶劑(B)包含該醇類或二醇類化合物(B-4),且其含量落於上述範圍時,則所製得之液晶配向劑之噴墨印刷塗佈性較佳。If the solvent (B) contains the alcohol or diol compound (B-4), and the content thereof falls within the above range, the obtained liquid crystal alignment agent has better inkjet printing coatability.
較佳地,本發明之溶劑(B)更可包含式(2)所示之化合物(B-5):式(2) 式(2)中,n為1或2,且R1 、R2 為C1 至C4 之烷基。Preferably, the solvent (B) of the present invention may further comprise the compound (B-5) represented by the formula (2): Formula (2) In formula (2), n is 1 or 2, and R 1 and R 2 are C 1 to C 4 alkyl groups.
式(2)所示之化合物(B-5)可為二甘醇乙基甲基醚、二甘醇二乙基醚、二甘醇異丙基甲基醚、二甘醇丁基甲基醚、乙二醇二甲基醚、乙二醇二乙基醚、乙二醇二丙基醚、乙二醇二丁基醚等,且可以單獨使用或者組合多種來使用。The compound (B-5) represented by the formula (2) can be diethylene glycol ethyl methyl ether, diethylene glycol diethyl ether, diethylene glycol isopropyl methyl ether, diethylene glycol butyl methyl ether, ethylene glycol Glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dipropyl ether, ethylene glycol dibutyl ether, and the like can be used alone or in combination.
基於該溶劑(B)的含量為100重量%,該式(2)所示之化合物(B-5)的含量通常為1重量%至20重量%;較佳為3重量%至20重量%;更佳為5重量%至20重量%。Based on the content of the solvent (B) being 100% by weight, the content of the compound (B-5) represented by the formula (2) is usually 1% by weight to 20% by weight; preferably 3% by weight to 20% by weight; More preferably, it is 5% by weight to 20% by weight.
若該溶劑(B)包含該式(2)所示之化合物(B-5),且其含量落於上述範圍時,則所製得之液晶配向劑之噴墨印刷塗佈性較佳。If the solvent (B) contains the compound (B-5) represented by the formula (2), and its content falls within the above-mentioned range, the obtained liquid crystal alignment agent has better inkjet printing coatability.
本發明之溶劑(B)更可包含其他溶劑(B-6),例如N-甲基-2-吡咯烷酮、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基己內醯胺、二甲基亞碸、四甲基尿素、六甲基磷醯胺、γ-丁內酯等;亦可併用甲醇、乙醇、異丙醇、正丁醇、環己醇、二乙基醚、丙酮、甲基乙基酮、環己酮、乙酸甲酯、乙酸乙酯、四氫呋喃、二氯甲烷、三氯甲烷、1,2-二氯乙烷、苯、甲苯、二甲苯、正己烷、正庚烷、正辛烷等。< 液晶配向劑的製造方法 > The solvent (B) of the present invention may further comprise other solvents (B-6), such as N-methyl-2-pyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl caprolactone, dimethyl sulfoxide, tetramethyl urea, hexamethyl phosphamide, γ-butyrolactone, etc.; also can be used in combination with methanol, ethanol, isopropanol, n-butanol, cyclic Hexanol, diethyl ether, acetone, methyl ethyl ketone, cyclohexanone, methyl acetate, ethyl acetate, tetrahydrofuran, dichloromethane, chloroform, 1,2-dichloroethane, benzene, toluene , xylene, n-hexane, n-heptane, n-octane, etc. < The manufacturing method of liquid crystal aligning agent >
液晶配向劑的製造方法並無特別的限制,可採用一般的混合方法來製備。舉例而言,先將四羧酸二酐組份(a)及二胺組份(b)混合均勻,以反應形成一聚合物(A)。接著,將聚合物(A)於溫度為0°C至200°C的條件下加入溶劑(B),並可選擇性地添加添加劑(C),以攪拌裝置持續攪拌至溶解即可。較佳地,於20°C至60°C的溫度下,將溶劑(B)添加至聚合組成物中。The manufacturing method of the liquid crystal aligning agent is not particularly limited, and it can be prepared by a general mixing method. For example, the tetracarboxylic dianhydride component (a) and the diamine component (b) are mixed uniformly to react to form a polymer (A). Next, the polymer (A) is added to the solvent (B) at a temperature of 0 ° C to 200 ° C, and the additive (C) can be optionally added, and the stirring device is continuously stirred until dissolved. Preferably, the solvent (B) is added to the polymer composition at a temperature of 20°C to 60°C.
較佳地,於25°C時,本發明之液晶配向劑的黏度通常為15 cps至35 cps,較佳為17 cps至33 cps,更佳為20 cps至30 cps。 <液晶配向膜的製造方法>Preferably, at 25°C, the viscosity of the liquid crystal alignment agent of the present invention is usually 15 cps to 35 cps, preferably 17 cps to 33 cps, more preferably 20 cps to 30 cps. <Manufacturing method of liquid crystal alignment film>
本發明的液晶配向膜可由上述的液晶配向劑所形成。The liquid crystal alignment film of the present invention can be formed from the above-mentioned liquid crystal alignment agent.
具體而言,液晶配向膜的製備方式例如可以是:將液晶配向劑利用輥塗佈法、旋轉塗佈法、印刷法或噴墨法(ink-jet)等方法,塗佈在基板的表面上,形成預塗層,較佳為噴墨法。接著,對預塗層進行預烤處理(pre-bake treatment)、後烤處理(post-bake treatment)及配向處理(alignment treatment)後而製得形成了液晶配向膜的基板。Specifically, the preparation method of the liquid crystal alignment film can be, for example, coating the liquid crystal alignment agent on the surface of the substrate by a roll coating method, a spin coating method, a printing method or an ink-jet method. , to form a precoat, preferably an inkjet method. Next, the pre-coat layer is subjected to pre-bake treatment, post-bake treatment, and alignment treatment to prepare a substrate with a liquid crystal alignment film formed thereon.
較佳地,本發明之液晶配向膜的製造方法,係藉由噴墨印刷法使前述之液晶配向劑形成一液晶配向膜。Preferably, the manufacturing method of the liquid crystal alignment film of the present invention is to form a liquid crystal alignment film from the aforementioned liquid crystal alignment agent by an inkjet printing method.
預烤處理的目的在於使預塗層中的有機溶劑揮發。預烤處理的操作溫度較佳為30°C至120°C,且更佳為40°C至110°C,尤佳為50°C至100°C。The purpose of the prebake treatment is to volatilize the organic solvent in the precoat. The operating temperature of the prebaking treatment is preferably 30°C to 120°C, more preferably 40°C to 110°C, and particularly preferably 50°C to 100°C.
配向處理並無特別的限制,可將尼龍、人造絲或棉類等纖維所做成的布料纏繞在滾筒上,並以一定方向摩擦進行配向。The alignment treatment is not particularly limited, and a fabric made of fibers such as nylon, rayon, or cotton can be wound around a drum and rubbed in a certain direction for alignment.
後烤處理步驟的目的在於使預塗層中的聚合物再進一步進行脫水閉環(醯亞胺化)反應。後烤處理的操作溫度較佳為150°C至300°C,更佳為180°C至280°C,尤佳為200°C至250°C。< 液晶顯示元件及其製造方法 > The purpose of the post-bake treatment step is to subject the polymer in the precoat to a further dehydration ring closure (imidization) reaction. The operating temperature of the post-baking treatment is preferably 150°C to 300°C, more preferably 180°C to 280°C, particularly preferably 200°C to 250°C. < Liquid crystal display element and its manufacturing method >
本發明的液晶顯示元件包括由本發明的液晶配向劑所形成的液晶配向膜。液晶顯示元件的製作方式為本技術領域者所周知。因此,以下僅簡單地進行陳述。The liquid crystal display element of the present invention includes a liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention. The manufacturing method of a liquid crystal display element is well known to those skilled in the art. Therefore, the following statements are made only briefly.
圖1是根據本發明一實施例的液晶顯示元件的側視圖。液晶顯示元件100包括第一單元110、第二單元120及液晶單元130,其中第二單元120與第一單元110分離配置,且液晶單元130設置在第一單元110與第二單元120之間。FIG. 1 is a side view of a liquid crystal display element according to an embodiment of the present invention. The liquid
第一單元110包括第一基板112、第一導電膜114及第一液晶配向膜116,其中第一導電膜114形成在第一基板112的表面。另外,第一導電膜114位於第一基板112與第一液晶配向膜116之間,並且第一液晶配向膜116位於液晶單元130的一側。The
第二單元120包括第二基板122、第二導電膜124及第二液晶配向膜126,其中第二導電膜124形成在第二基板122的表面。另外,第二導電膜124位於第二基板122與第二液晶配向膜126之間,並且第二液晶配向膜126位於液晶單元130的另一側。換言之,液晶單元130是位於第一液晶配向膜116與第二液晶配向膜126之間。The second unit 120 includes a second substrate 122 , a second conductive film 124 and a second liquid crystal alignment film 126 , wherein the second conductive film 124 is formed on the surface of the second substrate 122 . In addition, the second conductive film 124 is located between the second substrate 122 and the second liquid crystal alignment film 126 , and the second liquid crystal alignment film 126 is located on the other side of the
第一基板112與第二基板122是選自於透明材料等,其中,透明材料包括但不限於用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸或聚碳酸酯等。The
第一導電膜114與第二導電膜124的材質是擇自於氧化錫(SnO2
)、氧化銦-氧化錫(In2
O3
-SnO2
)等。The materials of the first
第一液晶配向膜116及第二液晶配向膜126各自為上述的液晶配向膜,其作用在於使液晶單元130形成預傾角。此外,當施予第一導電膜114與第二導電膜124電壓時,第一導電膜114與第二導電膜124之間可產生電場。此電場可驅動液晶單元130,進而使液晶單元130中的液晶分子的排列發生改變。The first liquid
液晶單元130所使用的液晶可單獨使用或混合使用,液晶包括但不限於二胺基苯類液晶、噠嗪(pyridazine)類液晶、希夫氏鹼(shiff Base)類液晶、氧化偶氮基(azoxy)類液晶、聯苯(biphenyl)類液晶、苯基環己烷(phenylcyclohexane)類液晶、酯(ester)類液晶、三聯苯(terphenyl)、聯苯環己烷(biphenylcyclohexane)類液晶、嘧啶(pyrimidine)類液晶、二氧六環(dioxane)類液晶、雙環辛烷(bicyclooctane)類液晶或立方烷(cubane)類液晶等,且可視需求再添加例如是氯化膽固醇(cholesteryl chloride)、膽固醇壬酸酯(cholesteryl nonanoate)、膽固醇碳酸酯(cholesteryl carbonate)等的膽固醇型液晶、或是以商品名「C-15」、「CB-15」(默克公司製造)的對掌(chiral)劑等,或者是對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等強介電性(ferroelectric)類液晶。The liquid crystals used in the
茲以下列實例予以詳細說明本發明,唯並不意謂本發明僅侷限於此等實例所揭示之內容。[ 聚合物 (A) 之製備 ] < 合成例 A-1-1> The following examples are used to illustrate the present invention in detail, but it is not intended that the present invention is limited to the contents disclosed by these examples. [ Preparation of Polymer (A) ] < Synthesis Example A-1-1>
在容積500毫升的四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,在四頸錐瓶中,加入0.035莫耳的對-二胺苯(簡稱為b-1)、0.015莫耳的表1所示之b-4及80克的N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidone,簡稱為NMP),並於室溫下攪拌至溶解。接著,加入0.05莫耳的2,3,5-三羧基環戊基醋酸二酐(簡稱為a-1)以及20克的NMP,並於室溫下反應2小時。待反應結束後,將反應溶液倒入1500毫升水中,以使聚合物析出。然後,過濾所得的聚合物,並重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60°C進行乾燥後,即可得聚合物(A-1-1)。< 合成例 A-1-2 及 A-1-3> A nitrogen inlet, a stirrer, a condenser and a thermometer were set on a four-necked conical flask with a volume of 500 ml, and nitrogen was introduced. Then, in a four-necked conical flask, add 0.035 mol of p-diamine benzene (abbreviated as b-1), 0.015 mol of b-4 shown in Table 1 and 80 grams of N-methyl-2- Pyrrolidone (N-methyl-2-pyrrolidone, referred to as NMP), and stirred at room temperature until dissolved. Next, 0.05 mol of 2,3,5-tricarboxycyclopentylacetic dianhydride (abbreviated as a-1) and 20 g of NMP were added, and the mixture was reacted at room temperature for 2 hours. After the reaction was completed, the reaction solution was poured into 1500 ml of water to precipitate the polymer. Then, the obtained polymer was filtered, washed with methanol and filtered three times repeatedly, placed in a vacuum oven, and dried at a temperature of 60° C. to obtain the polymer (A-1-1). < Synthesis Examples A-1-2 and A-1-3>
合成例A-1-2及A-1-3是以與合成例A-1-1相同之步驟來製備該聚合物,不同之地方在於:改變四羧酸二酐組份或二胺組份之種類及其使用量,如表1所示。< 合成例 A-2-1> Synthesis Examples A-1-2 and A-1-3 are prepared by the same procedure as Synthesis Example A-1-1, except that the tetracarboxylic dianhydride component or the diamine component is changed. The types and amounts used are shown in Table 1. < Synthesis example A-2-1>
在容積500毫升的四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,在四頸錐瓶中,加入0.04莫耳的4,4’-二胺基二苯基甲烷(簡稱為b-2)、0.01莫耳的表1所示之b-4及80克的N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidone,簡稱為NMP),並於室溫下攪拌至溶解。接著,加入0.05莫耳的2,3,5-三羧基環戊基醋酸二酐(簡稱為a-1)以及20克的NMP。於室溫下反應6小時後,加入97克的NMP、0.01莫耳的醋酸酐及0.02莫耳的吡啶,升溫至120°C,且持續攪拌2小時,以進行醯亞胺化反應。待反應結束後,將反應溶液倒入1500毫升水中,以使聚合物析出。然後,過濾所得的聚合物,並重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60°C進行乾燥後,即可得聚合物(A-2-1)。< 合成例 A-2-2 至 A-2-10> A nitrogen inlet, a stirrer, a condenser and a thermometer were set on a four-necked conical flask with a volume of 500 ml, and nitrogen was introduced. Then, in a four-necked conical flask, add 0.04 mol of 4,4'-diaminodiphenylmethane (abbreviated as b-2), 0.01 mol of b-4 shown in Table 1 and 80 g of N-methyl-2-pyrrolidone (N-methyl-2-pyrrolidone, abbreviated as NMP), and stirred at room temperature until dissolved. Next, 0.05 moles of 2,3,5-tricarboxycyclopentylacetic dianhydride (abbreviated as a-1) and 20 grams of NMP were added. After reacting at room temperature for 6 hours, 97 g of NMP, 0.01 mol of acetic anhydride and 0.02 mol of pyridine were added, the temperature was raised to 120°C, and stirring was continued for 2 hours to carry out imidization reaction. After the reaction was completed, the reaction solution was poured into 1500 ml of water to precipitate the polymer. Then, the obtained polymer was filtered, washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60° C. to obtain the polymer (A-2-1). < Synthesis Examples A-2-2 to A-2-10>
合成例A-2-2至A-2-10是以與合成例A-2-1相同之步驟來製備該聚合物,不同之地方在於:改變四羧酸二酐組份及二胺組份之種類及其使用量,以及改變脫水劑、脫水閉環反應的觸媒之使用量及反應溫度,如表1所示。 表1:
秤取100重量份的聚合物(A-1-1)、79重量份的N-乙基-2-吡咯烷酮(簡稱為B-1-1)、1重量份的4,6-二甲基-2-庚酮(B-2)及20重量份的2,6-二甲基-4-庚酮(B-3),並且在室溫下攪拌混合而形成實施例1的液晶配向劑。100 parts by weight of polymer (A-1-1), 79 parts by weight of N-ethyl-2-pyrrolidone (abbreviated as B-1-1), 1 part by weight of 4,6-dimethyl- 2-heptanone (B-2) and 20 parts by weight of 2,6-dimethyl-4-heptanone (B-3) were stirred and mixed at room temperature to form the liquid crystal aligning agent of Example 1.
將該液晶配向劑進行各檢測項目評價,所得結果如表3所示。< 實施例 2 至 15 及比較例 1 至 3> The liquid crystal aligning agent was evaluated for each test item, and the results obtained are shown in Table 3. < Examples 2 to 15 and Comparative Examples 1 to 3>
實施例2至15及比較例1至3是以與實施例1相同之步驟來製備該液晶配向劑,不同之地方在於:改變聚合物組成物、溶劑及添加劑之種類及其使用量,如表2-1、表2-2及表3所示。將該等液晶配向劑進行各檢測項目評價,所得結果如表2-1、表2-2及表3所示。 表2-1:
醯亞胺化率係指透過聚醯亞胺聚合物中之醯胺酸官能基之數目和醯亞胺環之數目的合計量為基準,來計算醯亞胺環之數目所佔的比例,並以百分率表示。The imidization rate refers to the ratio of the number of imide rings to be calculated based on the total amount of the number of imide functional groups and the number of imine rings in the polyimide polymer, and Expressed as a percentage.
醯亞胺化率之檢測方法係對上述之合成例A-1-1至A-2-10及的聚合物(A)進行減壓乾燥後,將前述之聚合物(A)溶解於適當的氘化溶劑(deuteration solvent;例如氘化二甲基亞碸)中,並以四甲基矽烷作為基準物質,於室溫(例如25°C)下測定1 H-NMR(氫原子核磁共振)之結果,經下式計算聚合物(A)之醯亞胺化率(%): The method for detecting the imidization rate is to dry the polymers (A) in the above-mentioned synthesis examples A-1-1 to A-2-10 under reduced pressure, and then dissolve the above-mentioned polymers (A) in a suitable In a deuterated solvent (such as deuterated dimethyl sulfoxide), and using tetramethylsilane as a reference material, the 1 H-NMR (hydrogen nuclear magnetic resonance) was measured at room temperature (such as 25°C). As a result, the imidization rate (%) of the polymer (A) was calculated by the following formula:
於式中,Δ1代表NH基質子在10ppm附近的化學位移(chemical shift)所產生之峰值(peak)面積,Δ2代表其他質子之峰值面積,且α代表聚合物組成物(A)中該等聚合物的聚醯胺酸前趨物中NH基的1個質子相對於其他質子個數比例。< 噴墨印刷塗佈性 > In the formula, Δ1 represents the peak area generated by the chemical shift of the NH proton around 10 ppm, Δ2 represents the peak area of other protons, and α represents the polymerization in the polymer composition (A) The ratio of the number of one proton of the NH group relative to the other protons in the polyamide precursor of the product. < Inkjet Printing Coatability >
將附有ITO製成的透明電極的玻璃基板,於200°C之加熱板上加熱一分鐘,續以紫外線/臭氧清潔,使透明電極表面的水滴接觸角為10°以下,以作為後續塗佈液晶配向劑的基板。The glass substrate with the transparent electrode made of ITO was heated on a hot plate at 200°C for one minute, and then cleaned with ultraviolet/ozone, so that the contact angle of water droplets on the surface of the transparent electrode was less than 10°, as a follow-up coating. Liquid crystal alignment agent substrate.
取前述實施例1至15及比較例1至3的液晶配向劑,使用噴墨塗佈機(芝浦Mechatronics製)塗佈於上述玻璃基板表面之透明電極的表面。塗佈條件為2,500次/(噴嘴•分鐘),塗佈量250 mg/10秒進行二次來回(共4次)。完成塗佈後,靜置1分鐘,續加熱形成膜厚0.1 μm之塗膜。於獲得上述塗膜後,以干涉條紋測量燈(鈉燈)照射,並以肉眼觀察,對其不均勻(unevenness)及收縮(cissing)程度進行評價。加熱溫度分別為50°C、60°C及80°C,評價標準如下: ◎:優良,於上述三個溫度下皆無不均勻及收縮之情形; ○:良好,於其中一個溫度下有不均勻及/或收縮之情形; △:可,於其中二個溫度下有不均勻及/或收縮之情形;及 ╳:不良,上述三個溫度下皆有不均勻及/或收縮之情形。The liquid crystal aligning agents of the aforementioned Examples 1 to 15 and Comparative Examples 1 to 3 were taken and coated on the surface of the transparent electrode on the surface of the glass substrate using an ink jet coater (manufactured by Shibaura Mechatronics). The coating conditions were 2,500 times/(nozzle•min), and the coating amount was 250 mg/10 seconds, and two round trips were performed (4 times in total). After finishing the coating, let it stand for 1 minute, and continue heating to form a coating film with a thickness of 0.1 μm. After the above coating film was obtained, it was irradiated with an interference fringe measuring lamp (sodium lamp) and observed with the naked eye to evaluate the degree of unevenness and cissing. The heating temperatures were 50°C, 60°C, and 80°C, respectively, and the evaluation criteria were as follows: ◎: excellent, no unevenness and shrinkage at the above three temperatures; ○: good, unevenness at one of the temperatures and/or shrinkage; △: OK, unevenness and/or shrinkage at two of the temperatures; and ╳: Bad, unevenness and/or shrinkage at all three temperatures.
上述實施例僅為說明本發明之原理及其功效,而非限制本發明。習於此技術之人士對上述實施例所做之修改及變化仍不違背本發明之精神。本發明之權利範圍應如後述之申請專利範圍所列。The above-mentioned embodiments are only to illustrate the principle and effect of the present invention, but not to limit the present invention. Modifications and changes made to the above embodiments by those skilled in the art still do not violate the spirit of the present invention. The scope of the rights of the present invention should be listed in the scope of the patent application described later.
100‧‧‧液晶顯示元件110‧‧‧第一單元112‧‧‧第一基板114‧‧‧第一導電膜116‧‧‧第一液晶配向膜120‧‧‧第二單元122‧‧‧第二基板124‧‧‧第二導電膜126‧‧‧第二液晶配向膜130‧‧‧液晶單元100‧‧‧
圖1係根據本發明一實施例的液晶顯示元件的側視圖。FIG. 1 is a side view of a liquid crystal display element according to an embodiment of the present invention.
100‧‧‧液晶顯示元件 100‧‧‧LCD components
110‧‧‧第一單元 110‧‧‧Unit 1
112‧‧‧第一基板 112‧‧‧First substrate
114‧‧‧第一導電膜 114‧‧‧First Conductive Film
116‧‧‧第一液晶配向膜 116‧‧‧First liquid crystal alignment film
120‧‧‧第二單元 120‧‧‧Unit 2
122‧‧‧第二基板 122‧‧‧Second board
124‧‧‧第二導電膜 124‧‧‧Second Conductive Film
126‧‧‧第二液晶配向膜 126‧‧‧Second liquid crystal alignment film
130‧‧‧液晶單元 130‧‧‧LCD unit
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107122210A TWI767019B (en) | 2018-06-28 | 2018-06-28 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN201910520576.3A CN110655928B (en) | 2018-06-28 | 2019-06-17 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107122210A TWI767019B (en) | 2018-06-28 | 2018-06-28 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202000731A TW202000731A (en) | 2020-01-01 |
TWI767019B true TWI767019B (en) | 2022-06-11 |
Family
ID=69028633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107122210A TWI767019B (en) | 2018-06-28 | 2018-06-28 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110655928B (en) |
TW (1) | TWI767019B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201026784A (en) * | 2009-01-08 | 2010-07-16 | Sharp Kk | Composition for forming liquid crystal alignment film and liquid crystal display device |
TW201821600A (en) * | 2016-08-10 | 2018-06-16 | 日商日產化學工業股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5077048B2 (en) * | 2007-05-02 | 2012-11-21 | Jsr株式会社 | Vertical alignment type liquid crystal alignment agent |
JP5930239B2 (en) * | 2012-10-18 | 2016-06-08 | 日産化学工業株式会社 | Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element |
KR102159410B1 (en) * | 2013-03-14 | 2020-09-23 | 제이엔씨 주식회사 | Liquid crystal aligning agents and liquid crystal display devices |
-
2018
- 2018-06-28 TW TW107122210A patent/TWI767019B/en active
-
2019
- 2019-06-17 CN CN201910520576.3A patent/CN110655928B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201026784A (en) * | 2009-01-08 | 2010-07-16 | Sharp Kk | Composition for forming liquid crystal alignment film and liquid crystal display device |
TW201821600A (en) * | 2016-08-10 | 2018-06-16 | 日商日產化學工業股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
Also Published As
Publication number | Publication date |
---|---|
CN110655928A (en) | 2020-01-07 |
CN110655928B (en) | 2023-12-26 |
TW202000731A (en) | 2020-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5444690B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
JP5787198B2 (en) | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element provided with this liquid crystal aligning film | |
US8962739B2 (en) | Liquid crystal alignment agent, and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent | |
JP4645823B2 (en) | Vertical liquid crystal aligning agent and vertical liquid crystal display element | |
KR20070008422A (en) | Liquid crystal aligning agent and liquid crystal display element | |
KR20080073235A (en) | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element | |
JP5071662B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
CN110499164A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
JP5099350B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
CN109207170B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
JP5067570B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP4573039B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
JP4539836B2 (en) | Liquid crystal aligning agent and horizontal electric field type liquid crystal display element | |
JP2007316625A (en) | Vertical alignment type liquid crystal aligning agent and vertical alignment type liquid crystal display device | |
JP4788890B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
TWI767019B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
CN108003896B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
TWI644945B (en) | Liquid crystal alignment agent and its application | |
CN107779207B (en) | Liquid crystal alignment agent and its application | |
TWI660981B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having the same | |
TW202246387A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
TW202246388A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
JP2010282105A (en) | Liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display element |